trial · primary record
LNCB74
Ovarian Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 145 |
| Primary completion | 2027-12 |
| Primary endpoint | Evaluate the safety and tolerability of LNCB74 |
| Registry ID | NCT06774963 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:13.926Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06774963
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.